Table V. Ispinesib plasma pharmacokinetic parameters by dose level.
Dose level mg/m2/dose | Patient | Cmax (ng/mL) |
AUClast (hr*ng/mL) |
AUCINF (hr*ng/mL) |
t1/2 (hr) |
Clearance (L/hr/m2) |
Vss (L/m2) |
|
---|---|---|---|---|---|---|---|---|
5 | 737478** | 86 | 945 | 1662 | 44 | 3.0 | 177 | * |
757897 | 145 | 908 | 938 | 9 | 5.3 | 61 | ||
7 | 744676 | 181 | 1319 | 1449 | 14 | 4.8 | 84 | * |
758892** | 244 | 3716 | 5733 | 32 | 1.2 | 51 | ||
767535 | 1900 | 4090 | 4596 | 18 | 1.5 | 24 | * | |
769075 | 75 | 851 | 970 | 15 | 7.2 | 145 | ||
9 | 763246 | 1880 | 4814 | 5243 | 16 | 1.7 | 23 | * |
763770 | 281 | 2506 | 3811 | 33 | 2.4 | 102 | ||
769877 | 149 | 1526 | 1865 | 19 | 4.8 | 118 | ||
12 | 764399 | 149 | 819 | 890 | 13 | 13.5 | 193 | |
771172** | 204 | 732 | 1690 | 8 | 7.1 | 83 |
Protocol deviation with samples obtained from same venous access site as drug administration; concentrations obtained may be overestimates;
AUC extrapolated values for these patients were >30% (fewer data points were available for these patients).